SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - FRA:SHL - DE000SHL1006 - Common Stock
49.53 EUR
+0.17 (+0.34%)
SHL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
SHL had a positive operating cash flow in the past year.
In the past 5 years SHL has always been profitable.
SHL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SHL's Return On Assets of 4.87% is fine compared to the rest of the industry. SHL outperforms 63.33% of its industry peers.
The Return On Equity of SHL (12.29%) is better than 75.00% of its industry peers.
SHL's Return On Invested Capital of 7.89% is fine compared to the rest of the industry. SHL outperforms 73.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 8.76%.
The last Return On Invested Capital (7.89%) for SHL is above the 3 year average (5.87%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
Looking at the Profit Margin, with a value of 9.29%, SHL is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SHL has declined.
SHL has a Operating Margin of 13.76%. This is in the better half of the industry: SHL outperforms 63.33% of its industry peers.
SHL's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 38.76%, SHL is not doing good in the industry: 78.33% of the companies in the same industry are doing better.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
Compared to 1 year ago, SHL has more shares outstanding
The number of shares outstanding for SHL has been increased compared to 5 years ago.
Compared to 1 year ago, SHL has an improved debt to assets ratio.
2.2 Solvency
SHL has an Altman-Z score of 2.13. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.13, SHL is in line with its industry, outperforming 45.00% of the companies in the same industry.
SHL has a debt to FCF ratio of 5.10. This is a neutral value as SHL would need 5.10 years to pay back of all of its debts.
The Debt to FCF ratio of SHL (5.10) is comparable to the rest of the industry.
SHL has a Debt/Equity ratio of 0.66. This is a neutral value indicating SHL is somewhat dependend on debt financing.
SHL has a worse Debt to Equity ratio (0.66) than 71.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.13 |
ROIC/WACC1.27
WACC6.22%
2.3 Liquidity
SHL has a Current Ratio of 1.12. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
SHL's Current ratio of 1.12 is on the low side compared to the rest of the industry. SHL is outperformed by 71.67% of its industry peers.
SHL has a Quick Ratio of 1.12. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.77, SHL is doing worse than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
SHL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.21%, which is quite good.
The Earnings Per Share has been growing slightly by 7.27% on average over the past years.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 5.85% in the last year.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
Based on estimates for the next years, SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.71% on average per year.
SHL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.62% yearly.
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.81, which indicates a rather expensive current valuation of SHL.
Based on the Price/Earnings ratio, SHL is valued a bit cheaper than the industry average as 76.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.89, SHL is valued a bit cheaper.
SHL is valuated rather expensively with a Price/Forward Earnings ratio of 18.95.
Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
SHL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.99.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.81 | ||
| Fwd PE | 18.95 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than the industry average as 61.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 83.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.16 | ||
| EV/EBITDA | 15.15 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHL does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)2.15
PEG (5Y)2.86
EPS Next 2Y8.26%
EPS Next 3Y9.53%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 1.92%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.23, SHL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.31, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.92% |
5.2 History
The dividend of SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.08% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.08%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
FRA:SHL (10/24/2025, 7:00:00 PM)
49.53
+0.17 (+0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.87B
Revenue(TTM)23.38B
Net Income(TTM)2.17B
Analysts83.7
Price Target61.88 (24.93%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.92% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0%
PT rev (3m)0.1%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-8.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-1.03%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.81 | ||
| Fwd PE | 18.95 | ||
| P/S | 2.39 | ||
| P/FCF | 18.16 | ||
| P/OCF | 14.53 | ||
| P/B | 3.16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.15 |
EPS(TTM)2.38
EY4.81%
EPS(NY)2.61
Fwd EY5.28%
FCF(TTM)2.73
FCFY5.51%
OCF(TTM)3.41
OCFY6.88%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)2.15
PEG (5Y)2.86
Graham Number28.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexgc growth 3Y-8.79%
ROICexgc growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 2.13 |
F-Score8
WACC6.22%
ROIC/WACC1.27
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.21%
EBIT Next 3Y20.47%
EBIT Next 5Y15.42%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 20.81 and the Price/Book (PB) ratio is 3.16.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.08%.